Efficacy and safety of undenatured type II collagen in patients with knee osteoarthritis: a multicenter, prospective, double-blind, placebo-controlled, randomized trial
- 作者: Alekseeva L.1, Kashevarova N.1, Taskina E.1, Strebkova E.1, Korotkova T.1, Sharapova E.1, Savushkina N.1, Lila A.1, Shostak N.2, Mazurov V.3,4,5, Nesterovich I.6,7, Dedkova V.8, Vasilyuk V.8, Egorova N.9, Leontyeva M.10, Yakupova S.11, Vinogradova I.12, Sorotskaya V.13, Shirokova L.14,15
-
隶属关系:
- Nasonova Research Institute of Rheumatology
- Pirogov Russian National Research Medical University
- Mechnikov North-Western State Medical University
- Clinical Rheumatology Hospital No. 25
- Medical and Sanitary Unit No. 157 LLC
- Pavlov First Saint Petersburg State Medical University
- Meili LLC
- Research Center “Eco-safety” LLC
- Health Energy LLC
- Zvezdnaya Clinic LLC
- Kazan State Medical University
- Ulyanovsk Regional Clinical Hospital
- Tula State University
- Yaroslavl State Medical University
- Institute of Professional Training
- 期: 卷 96, 编号 5 (2024)
- 页面: 500-509
- 栏目: Original articles
- URL: https://journals.rcsi.science/0040-3660/article/view/256833
- DOI: https://doi.org/10.26442/00403660.2024.05.202788
- ID: 256833
如何引用文章
全文:
详细
Background. Non-pharmacological treatments based on collagen as a dietary supplement are emerging as a new area of interest to support preventive or therapeutic effects in patients with osteoarthritis (OA).
Aim. In a multicenter, prospective, double-blind, placebo-controlled, randomized study, to evaluate the effectiveness and safety of the use of the Artneo complex containing undenatured chicken collagen type II in patients with OA of the knee joints.
Materials and methods. The study enrolled 212 outpatients from 12 centers in the Russian Federation with knee OA, stages II and III according to the Kellgren–Lawrence classification. The participants included 171 women (80.7%) and 41 men (19.3%), with an average age of 60.2±9.0 years (range: 40 to 75 years). The study population was randomly allocated in equal proportions into two groups using an interactive web response system (IWRS). Group 1 (Artneo) consisted of 106 patients who took one capsule of the drug once daily for 180 days. Group 2 (Placebo) also had 106 patients, with the dosage form and regimen identical to Group 1. During the treatment period, the following outcomes were assessed: WOMAC index, KOOS, pain according to VAS, quality of life using the EQ-5D questionnaire, and the need for NSAIDs. All patients underwent a clinical blood test, general urine analysis, biochemical blood test, and ultrasound examination of the affected knee joint.
Results. In a prospective, double-blind, placebo-controlled, randomized study, it was demonstrated that the Artneo combination, containing undenatured chicken collagen type II, has a positive effect on all clinical manifestations of OA: it effectively reduces pain, stiffness, and improves the functional state of joints and quality of life. It has a good safety profile and is superior to placebo in all parameters studied.
Conclusion. The results of the study confirm the good effectiveness and safety of the Artneo combination in patients with OA of the knee joints.
作者简介
Liudmila Alekseeva
Nasonova Research Institute of Rheumatology
Email: nat-kash@yandex.ru
ORCID iD: 0000-0001-7017-0898
доктор мед. наук, нач. отд. метаболических заболеваний костей и суставов
俄罗斯联邦, MoscowNatalia Kashevarova
Nasonova Research Institute of Rheumatology
Email: nat-kash@yandex.ru
ORCID iD: 0000-0001-8732-2720
кандидат мед. наук, науч. сотр. отд. метаболических заболеваний костей и суставов
俄罗斯联邦, MoscowElena Taskina
Nasonova Research Institute of Rheumatology
Email: nat-kash@yandex.ru
ORCID iD: 0000-0001-8218-3223
кандидат мед. наук, ст. науч. сотр. отд. метаболических заболеваний костей и суставов
俄罗斯联邦, MoscowEkaterina Strebkova
Nasonova Research Institute of Rheumatology
Email: nat-kash@yandex.ru
ORCID iD: 0000-0001-8130-5081
кандидат мед. наук, науч. сотр. отд. метаболических заболеваний костей и суставов
俄罗斯联邦, MoscowTatiana Korotkova
Nasonova Research Institute of Rheumatology
Email: nat-kash@yandex.ru
ORCID iD: 0000-0003-0394-9249
кандидат мед. наук, зав. 1-м ревматологическим отд-нием с терапевтическими койками
俄罗斯联邦, MoscowEvgeniia Sharapova
Nasonova Research Institute of Rheumatology
Email: nat-kash@yandex.ru
ORCID iD: 0000-0003-4242-8278
кандидат мед. наук, науч. сотр. отд. метаболических заболеваний костей и суставов
俄罗斯联邦, MoscowNatalya Savushkina
Nasonova Research Institute of Rheumatology
Email: nat-kash@yandex.ru
ORCID iD: 0000-0001-8562-6077
кандидат мед. наук, науч. сотр. отд. метаболических заболеваний костей и суставов
俄罗斯联邦, MoscowAleksander Lila
Nasonova Research Institute of Rheumatology
Email: nat-kash@yandex.ru
ORCID iD: 0000-0002-6068-3080
чл.-кор. РАН, доктор мед. наук, проф., директор
俄罗斯联邦, MoscowNadezhda Shostak
Pirogov Russian National Research Medical University
Email: nat-kash@yandex.ru
ORCID iD: 0000-0003-4669-1006
доктор мед. наук, проф., почет. проф., профессор кафедры факультетской терапии им. акад. А.И. Нестерова лечебного факультета
俄罗斯联邦, MoscowVadim Mazurov
Mechnikov North-Western State Medical University; Clinical Rheumatology Hospital No. 25; Medical and Sanitary Unit No. 157 LLC
Email: nat-kash@yandex.ru
ORCID iD: 0000-0002-0797-2051
акад. РАН, доктор мед. наук, проф., гл. науч. конс., директор Научно-исследовательского института ревматологии, зав. каф. терапии, ревматологии, экспертизы временной нетрудоспособности и качества медицинской помощи им. Э.Э. Эйхвальда, рук. Центра аутоиммунных заболеваний
俄罗斯联邦, Saint Petersburg; Saint Petersburg; Saint PetersburgIrina Nesterovich
Pavlov First Saint Petersburg State Medical University; Meili LLC
Email: nat-kash@yandex.ru
ORCID iD: 0000-0002-3199-9537
доктор мед. наук, проф. каф. госпитальной терапии им. акад. М.В. Черноруцкого с клиникой, рук. отд. кардио-ревматологии НИИ ревматологии и аллергологии научно-клинического исследовательского центра
俄罗斯联邦, Saint Petersburg; Saint PetersburgViktoriia Dedkova
Research Center “Eco-safety” LLC
Email: nat-kash@yandex.ru
врач-терапевт
俄罗斯联邦, Saint PetersburgVasiliy Vasilyuk
Research Center “Eco-safety” LLC
Email: nat-kash@yandex.ru
ORCID iD: 0000-0003-2503-4402
доктор мед. наук, профессор, рук. госпиталя
俄罗斯联邦, Saint PetersburgNatalia Egorova
Health Energy LLC
编辑信件的主要联系方式.
Email: nat-kash@yandex.ru
глав. врач
俄罗斯联邦, Saint PetersburgMarina Leontyeva
Zvezdnaya Clinic LLC
Email: nat-kash@yandex.ru
врач-кардиолог отд. клинических исследований
俄罗斯联邦, Saint PetersburgSvetlana Yakupova
Kazan State Medical University
Email: nat-kash@yandex.ru
ORCID iD: 0000-0002-8590-4839
кандидат мед. наук, доц. каф. госпитальной терапии
俄罗斯联邦, KazanIrina Vinogradova
Ulyanovsk Regional Clinical Hospital
Email: nat-kash@yandex.ru
ORCID iD: 0000-0001-5052-912X
кандидат мед. наук, зав. ревматологическим центром
俄罗斯联邦, UlyanovskValentina Sorotskaya
Tula State University
Email: nat-kash@yandex.ru
ORCID iD: 0000-0003-3684-7310
доктор мед. наук, проф. каф. внутренних болезней
俄罗斯联邦, TulaLarisa Shirokova
Yaroslavl State Medical University; Institute of Professional Training
Email: nat-kash@yandex.ru
доктор мед. наук, проф. каф. госпитальной терапии с профпатологией
俄罗斯联邦, Yaroslavl; Yaroslavl参考
- Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019;393(10182):1745-59. doi: 10.1016/S0140-6736(19)30417-9
- Vos T, Allen C, Arora M. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1545-602.
- Markets and Markets (2020) Osteoarthritis Therapeutics Market – Global Forecast to 2025. Available at: https://www.marketsandmarkets.com/Market-Reports/osteoarthritis-therapeutics-market- 209565994.html?gclid=CjwKCAjw2bmLBhBREiwAZ6ugo5Mqec4ajgZ8UxP4N6eR59eIIuOockof56d8Qu1ivJEQxmLS79_PVxoCKksQAvD_BwE. Accessed: 25.11.2023.
- Liew JW, King LK, Mahmoudian A, et al. A scoping review of how early-stage knee osteoarthritis has been defined. Osteoarthritis Cartilage. 2023;31(9):1234-41. doi: 10.1016/j.joca.2023.04.015
- Yusuf E. Pharmacologic and Non-Pharmacologic Treatment of Osteoarthritis. Curr Treat Options Rheum. 2016;2:111-25. doi: 10.1007/s40674-016-0042-y
- Curtis E, Fuggle N, Shaw S, et al. Safety of Cyclooxygenase-2 Inhibitors in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis. Drugs Aging. 2019;36(Suppl. 1):25-44. doi: 10.1007/s40266-019-00664-x
- Bruyère O, Honvo G, Veronese N, et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum. 2019;49(3):337-50. doi: 10.1016/j.semarthrit.2019.04.008
- Reginster JY, Veronese N. Highly purified chondroitin sulfate: a literature review on clinical efficacy and pharmacoeconomic aspects in osteoarthritis treatment. Aging Clin Exp Res. 2021;33(1):37-47. doi: 10.1007/s40520-020-01643-8
- Honvo G, Lengelé L, Charles A, et al. Role of Collagen Derivatives in Osteoarthritis and Cartilage Repair: A Systematic Scoping Review With Evidence Mapping. Rheumatol Ther. 2020;7(4):703-40. doi: 10.1007/s40744-020-00240-5
- Nimni ME, Harkness RD. Collagen. Volume 1. CRC Press; Boca Raton, FL, USA. 2018.
- Mahmood A, Patel D, Hickson B, et al. Recent Progress in Biopolymer-Based Hydrogel Materials for Biomedical Applications. Int J Mol Sci. 2022;23(3). doi: 10.3390/ijms23031415
- Castile JD, Taylor KM, Buckton G. The influence of incubation temperature and surfactant concentration on the interaction between dimyristoylphosphatidylcholine liposomes and poloxamer surfactants. Int J Pharm. 2001;221(1-2):197-209. doi: 10.1016/s0378-5173(01)00685-8
- Sbricoli L, Guazzo R, Annunziata M, et al. Selection of Collagen Membranes for Bone Regeneration: A Literature Review. Materials (Basel). 2020;13(3). doi: 10.3390/ma13030786
- Xu Q, Torres JE, Hakim M, et al. Collagen- and hyaluronic acid-based hydrogels and their biomedical applications. Mater Sci Eng R Rep. 2021;146. doi: 10.1016/j.mser.2021.100641
- El Blidi O, Omari NE, Balahbib A, et al. Extraction Methods, Characterization and Biomedical Applications of Collagen: A Review. Biointerface Res Appl Chem. 2021;11:13587-613. doi: 10.33263/BRIAC115.1358713613
- Rajabimashhadi Z, Gallo N, Salvatore L, Lionetto F. Collagen Derived from Fish Industry Waste: Progresses and Challenges. Polymers (Basel). 2023;15(3). doi: 10.3390/polym15030544
- Carr BP, Chen Z, Chung JHY, Wallace GG. Collagen Alignment via Electro-Compaction for Biofabrication Applications: A Review. Polymers (Basel). 2022;14(20). doi: 10.3390/polym14204270
- Sklenářová R, Akla N, Latorre MJ, et al. Collagen as a Biomaterial for Skin and Corneal Wound Healing. J Funct Biomater. 2022;13(4). doi: 10.3390/jfb13040249
- Gelse K, Pöschl E, Aigner T. Collagens – structure, function, and biosynthesis. Adv Drug Deliv Rev. 2003;55(12):1531-46. doi: 10.1016/j.addr.2003.08.002
- Inoue Y, Itoh H, Aoki M, et al. Accelerating effect of soy peptides containing collagen peptides on type I and III collagen levels in rat skin. Biosci Biotechnol Biochem. 2012;76(8):1549-51. doi: 10.1271/bbb.120088
- Minor AJ, Coulombe KLK. Engineering a collagen matrix for cell-instructive regenerative angiogenesis. J Biomed Mater Res B Appl Biomater. 2020;108(6):2407-16. doi: 10.1002/jbm.b.34573
- Abedinia A, Mohammadi Nafchi A, Sharifi M, et al. Poultry Gelatin: Characteristics, Developments, Challenges, and Future Outlooks as a Sustainable Alternative for Mammalian Gelatin. Trends Food Sci Technol. 2020;104:14-26. doi: 10.1016/j.tifs.2020.08.001
- Oliveira VDM, Assis CRD, Costa BDAM, et al. Physical, Biochemical, Densitometric and Spectroscopic Techniques for Characterization Collagen from Alternative Sources: A Review Based on the Sustainable Valorization of Aquatic by-Products. J Mol Struct. 2021;1224:129023. doi: 10.1016/j.molstruc.2020.129023.
- Fu Y, Therkildsen M, Aluko RE, Lametsch R. Exploration of collagen recovered from animal by-products as a precursor of bioactive peptides: Successes and challenges. Crit Rev Food Sci Nutr. 2019;59(13):2011-27. doi: 10.1080/10408398.2018.1436038
- Park KS, Park MJ, Cho ML, et al. Type II Collagen Oral Tolerance; Mechanism and Role in Collagen-Induced Arthritis and Rheumatoid Arthritis. Mod Rheumatol. 2009;19:581-9. doi: 10.3109/s10165-009-0210-0
- Kumar P, Bansal P, Rajnish RK, et al. Efficacy of undenatured collagen in knee osteoarthritis: review of the literature with limited meta-analysis. Am J Transl Res. 2023;15(9):5545-55.
- Gwinnutt JM, Wieczorek M, Rodríguez-Carrio J, et al. Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs. RMD Open. 2022;8(2). doi: 10.1136/rmdopen-2021-002167
- Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken). 2011;63 Suppl. 11:S240-52. doi: 10.1002/acr.20543
- Лила А.М., Алексеева Л.И., Беляева И.Б., и др. Резолюция Совета экспертов «Итоги многоцентрового рандомизированного двойного слепого плацебо-контролируемого исследования Артнео у пациентов с первичным остеоартритом коленного сустава II–III стадии. Современная ревматология. 2023;17(6):136-42 [Lila AM, Alekseeva LI, Belyaeva IB, et al. Resolution of the Council of Experts “Results of a multicenter, randomized, double-blind, placebo-controlled study of ARTNEO in patients with stage II–III primary knee osteoarthritis”. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2023;17(6):136-42 (in Russian)]. doi: 10.14412/1996-7012-2023-6-136-142
- Lugo JP, Saiyed ZM, Lane NE. Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study. Nutr J. 2016;15:14. doi: 10.1186/s12937-016-0130-8
- Schön C, Knaub K, Alt W, et al. UC-II Undenatured Type II Collagen for Knee Joint Flexibility: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study. J Integr Complement Med. 2022;28(6):540-8. doi: 10.1089/jicm.2021.0365
- Jain AV, Jain KA, Vijayaraghavan N. AflaB2® and Osteoarthritis: A Multicentric, Observational, Post-Marketing Surveillance Study in Indian Patients Suffering from Knee Osteoarthritis. Int J Res Orthop. 2020;7:110. doi: 10.18203/issn.2455-4510.IntJResOrthop20205570
- Мазуров В.И., Беляева И.Б., Трофимов Е.А., и др. Сравнение эффективности комбинации неденатурированного коллагена II типа, босвеллиевых кислот, метилсульфонилметана, витаминов С и D3 и комбинации хондроитина сульфата и глюкозамина гидрохлорида в терапии первичного остеоартрита коленного сустава. Терапевтический архив. 2023;95(12):1141-50 [Mazurov VI, Belyaeva IB, Trofimov EA, et al. Comparative efficacy of a combination of undenatured type II collagen, Boswellic acids, methylsulfonylmethane, vitamins C and D3 and a combination of chondroitin sulfate and glucosamine hydrochloride in the treatment of primary osteoarthritis of the knee join. Terapevticheskii Arkhiv (Ter. Arkh.). 2023;95(12):1141-50 (in Russian)]. doi: 10.26442/00403660.2023.12.202540
- Мазуров В.И., Алексеева Л.И., Беляева И.Б., и др. Эффективность, безопасность и перспективы применения комбинации нативного коллагена II типа, метилсульфонилметана, босвеллиевых кислот, витаминов С и D3 при остеоартрите коленных суставов: резолюция Совета экспертов. Терапевтический архив. 2024;96(1):68-74 [Mazurov VI, Alekseeva LI, Belyaeva IB, et al. Efficacy, safety and prospects of using a combination of native type II collagen, methylsulfonylmethane, boswellic acids, vitamin C and vitamin D3 in knee osteoarthritis: a resolution of the Expert panel. Terapevticheskii Arkhiv (Ter. Arkh.). 2024;96(1):68-74 (in Russian)]. doi: 10.26442/00403660.2024.1.202590